About the Event
Pressure BioSciences (OTC: PBIO) was the first company to safely bring super high pressure to research and manufacturing labs with the introduction of their innovative Pressure Cycling Technology (PCT) platform. Currently in use in over 200 academic, government, pharmaceutical, and biotech research labs around the world, the company has leveraged that expertise to create a full line of pressure-based technologies to benefit businesses in a wide range of industries.
PressureBio’s three platforms include:
- Pressure Cycling Technology: Used for the development of biopharmaceuticals, biomarker discovery, forensics and anti-bioterror research. Customers include: FDA, CDC, FBI, USDA, Harvard, Stanford, Cedars Sinai, MD Anderson Cancer Center, Sanofi, Genentech, Merck, Roche and others.
- BaroFold Services: Used to accelerate therapeutic protein development, manufacture follow-on biologics, and enable life-cycle management of protein therapeutics. Revenues from the sale and licensing of BaroFold have nearly tripled since last year and the company continues to see increased demand for the platform.
- Ultra Sheer Technology (UST): Imagine housepaint that never needs stirring. Milk that can sit on the shelf without refrigeration for months. CBD extracts that can be precisely dosed.. UST combines pressures as high as 45,000 PSI with PBIO’s patented nano-gap shear valve, which allows manufacturers to turn water insoluble extracts into stable, water-soluble nano-size formulations.
Join this webinar to hear from Pressure BioScience’s CEO, Richard Schumacher, as he talks about the unlimited potential of the company’s expanded portfolio and their newest subsidiary, PBI Agrochem, that uses UST to create organic, environmentally responsible pesticides, herbicides, and fertilizers that deliver the same results as traditional agrochemicals.